[1] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[2] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[3] |
YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang .
The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province
[J]. China Oncology, 2021, 31(7): 616-628.
|
[4] |
YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying .
Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(3): 203-211.
|
[5] |
ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li .
Advances in the treatment of BRAF V600-mutant non-small cell lung cancer
[J]. China Oncology, 2021, 31(12): 1145-1152.
|
[6] |
SHEN Yujia , FU Xiaolong .
Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer
[J]. China Oncology, 2021, 31(11): 1115-1125.
|
[7] |
HE Xi, JIAO Xiaodong, ZANG Yuansheng.
Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(1): 69-75.
|
[8] |
LU Xiaoteng, XU Qing.
A study on factors associated with recurrence of non-small cell lung cancer based on CT image features
[J]. China Oncology, 2020, 30(8): 636-640.
|
[9] |
KAI Jinyan , MA Qian , TONG Ying , XIE Suhong , HE Chengyan , SONG Lina , SUN Jing , ZHU Guangbo , LU Renquan , GUO Lin .
Diagnostic value of serum fibrin degradation complex (DR-70) in patients with colorectal cancer
[J]. China Oncology, 2020, 30(4): 293-298.
|
[10] |
ZHANG Longfu , YAO Jiamei , JIANG Dongxian , HOU Yingyong , ZHANG Xin .
BIM combined with Scribble predicts treatment effect from chemotherapy in advanced non-small cell lung cancer
[J]. China Oncology, 2020, 30(11): 865-871.
|
[11] |
FANG Yujia, ZHOU Juan, SU Chunxia.
Immune microenvironment for liver metastasis of non-small cell lung cancer and future intervention strategies
[J]. China Oncology, 2020, 30(10): 750-758.
|
[12] |
LI Yuan.
Personalized immunotherapy for lung cancer under the guidance of pathology
[J]. China Oncology, 2020, 30(10): 770-776.
|
[13] |
YANG Guang , ZHANG Kun , WANG Jun .
Expression of prospero-related homeobox protein 1 and its significance in non-small cell lung cancer
[J]. China Oncology, 2020, 30(10): 791-797.
|
[14] |
DONG Lei , ZHANG Zhongyan .
Regulatory effect of miR-1290 targeting IRF2 on proliferation and invasion of non-small cell lung cancer cells and its related mechanism
[J]. China Oncology, 2020, 30(1): 32-40.
|
[15] |
YE Ke, ZHENG Xiaoli, GE Hong, LI Xue, WANG Hao.
The role of TBRG4 in lung adenocarcinoma and its mechanism
[J]. China Oncology, 2019, 29(4): 265-271.
|